Peucedanocoumarin III
- CAS No.
- 130464-57-2
- Chemical Name:
- Peucedanocoumarin III
- Synonyms
- Peucedanocoumarin III;(2E)-2-Methyl-2-butenoic acid (9S,10R)-9-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-10-yl ester;2-Butenoic acid, 2-methyl-, (9S,10R)-9-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b']dipyran-10-yl ester, (2E)-
- CBNumber:
- CB13037459
- Molecular Formula:
- C21H22O7
- Molecular Weight:
- 386.4
- MDL Number:
- MOL File:
- 130464-57-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Peucedanocoumarin III ≥98% | 582906 | 5mg | $692 |
| Peucedanocoumarin III | FFA46457 | 10mg | $853.8 |
| Peucedanocoumarin III | FFA46457 | 25mg | $1392 |
| Peucedanocoumarin III | FFA46457 | 50mg | $2227 |
| Peucedanocoumarin III 95.07% | CS-0090712 | 1mg | $433 |
Peucedanocoumarin III price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Usbiological | 582906 | Peucedanocoumarin III ≥98% | 130464-57-2 | 5mg | $692 | 2026-06-03 | Buy |
| Biosynth | FFA46457 | Peucedanocoumarin III | 130464-57-2 | 10mg | $853.8 | 2026-06-04 | Buy |
| Biosynth | FFA46457 | Peucedanocoumarin III | 130464-57-2 | 25mg | $1392 | 2026-06-04 | Buy |
| Biosynth | FFA46457 | Peucedanocoumarin III | 130464-57-2 | 50mg | $2227 | 2026-06-04 | Buy |
| ChemScene | CS-0090712 | Peucedanocoumarin III 95.07% | 130464-57-2 | 1mg | $433 | 2026-06-04 | Buy |
Peucedanocoumarin III Chemical Properties,Uses,Production
Description
Peucedanocoumarin Ⅲ can induce rice resistance to blast disease.
Uses
Peucedanocoumarin III is an inhibitor of (alpha)-synuclein and Huntington protein aggregates that enhances the clearance of nuclear and cytoplasmic β23 aggregates and prevents cytotoxicity induced by disease-associated proteins (i.e., mutant Huntington proteins and α-synuclein). Peucedanocoumarin III may be used in Parkinson's disease research[1].
IC 50
α-synuclein Aggregation
References
[1] Sangwoo Ham, et al. Cell-Based Screen Using Amyloid Mimic β23 Expression Identifies Peucedanocoumarin III as a Novel Inhibitor of α-Synuclein and Huntingtin Aggregates. Mol Cells. 2019 Jun 30;42(6):480-494. DOI:10.14348/molcells.2019.0091
Peucedanocoumarin III Preparation Products And Raw materials
Raw materials
Preparation Products
Peucedanocoumarin III Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39037 | 58 |
| Sichuan Wei Keqi Biological Technology Co., Ltd. | 028-81700200 18116577057 | 3003855609@qq.com | China | 7750 | 56 |
| Wuxi Zhongkun Biochemical Technology Co., Ltd. | 0510-85629785 18013409632 | sales@reading-chemicals.com | China | 15178 | 58 |
| Wuhan ChemFaces Biochemical Co., Ltd. | 18607101326 15172504745 | aileen@chemfaces.com | China | 6905 | 55 |
| EMMX Biotechnology LLC | 888-539-0666 | info@emmx.com | United States | 8447 | 60 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 13636370518 | shyysw007@163.com | China | 89686 | 60 |
| Shanghai ChengShao Biological Technology Co., Ltd. | 021-61847300 13341622919 | shcss01@163.com | China | 4808 | 58 |
| Chengdu Push Bio-Technology Co., Ltd. | 028-85370565-229 18080489829 | 18080489829@163.com | China | 8380 | 60 |
| Shanghai Jizhi Biochemical Technology Co. Ltd. | 021-4009004166/18616739031 18616739031 | 3007523370@qq.com | China | 52678 | 58 |
| Zhejiang Lianshuo Biotechnology Co., Ltd. | 18616526224 | lianshuo@vip.126.com | China | 9607 | 58 |
